It has been reported that inactivating mutations in tumor suppressor genes such as CDKN2A/p16, TP53, and SMAD4 cooperate with KRAS mutations to cause aggressive tumor growth of pancreatic cancer [40]. The gene discussed is TP53; the disease is familial pancreatic carcinoma.